Natural IgM antibodies against phosphorylcholine (PC) have long been recognized for their protective effects against atherosclerosis and CVD, a finding corroborated by recent population-based studies, such as a Swedish cohort study involving women [66,67]. The gene discussed is CD40LG; the disease is atherosclerosis.